Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (601-610 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|August 19, 2024
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivoChien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, et al.
Ejhaem|August 19, 2024
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of <i>DUSP22</i> and <i>TP63</i>Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto, et al.
Ejhaem|August 19, 2024
Case series: Congenital enterovirus infection-associated haemophagocytic lymphohistiocytosis and subsequent neutropaeniaJustin Penner, James E Burns, Judith Breuer, et al.
Ejhaem|August 19, 2024
Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the <i>TCL1</i> represent peripheral T-cell lymphoma, NOS in a leukemic phase?David C Gajzer, Xueyan Chen, Daniel E Sabath, et al.
Ejhaem|June 19, 2024
Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignanciesKatherine Parks, Kendall Diebold, Donna Salzman, et al.
Ejhaem|June 19, 2024
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) databaseRayan Kaedbey, Donna Reece, Christopher P Venner, et al.
Ejhaem|June 19, 2024
Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemiaSina A Beer, Wolfgang Bethge, Christoph Faul, et al.
Ejhaem|June 19, 2024
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemiaJyoti Shaw, Abhilipsa Patra, Anjumana Khatun, et al.
Ejhaem|April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectBriony Shaw, Eliza Chung, Cameron Wellard, et al.
Ejhaem|April 18, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with <i>BCR::ABL1</i> fusionShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Pageof 93

Showing results (601-610 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|August 19, 2024
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivoChien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, et al.
Ejhaem|August 19, 2024
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of <i>DUSP22</i> and <i>TP63</i>Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto, et al.
Ejhaem|August 19, 2024
Case series: Congenital enterovirus infection-associated haemophagocytic lymphohistiocytosis and subsequent neutropaeniaJustin Penner, James E Burns, Judith Breuer, et al.
Ejhaem|August 19, 2024
Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the <i>TCL1</i> represent peripheral T-cell lymphoma, NOS in a leukemic phase?David C Gajzer, Xueyan Chen, Daniel E Sabath, et al.
Ejhaem|June 19, 2024
Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignanciesKatherine Parks, Kendall Diebold, Donna Salzman, et al.
Ejhaem|June 19, 2024
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) databaseRayan Kaedbey, Donna Reece, Christopher P Venner, et al.
Ejhaem|June 19, 2024
Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemiaSina A Beer, Wolfgang Bethge, Christoph Faul, et al.
Ejhaem|June 19, 2024
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemiaJyoti Shaw, Abhilipsa Patra, Anjumana Khatun, et al.
Ejhaem|April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectBriony Shaw, Eliza Chung, Cameron Wellard, et al.
Ejhaem|April 18, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with <i>BCR::ABL1</i> fusionShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Pageof 93